Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ebumab Holding ApS
APS
Active
CVR 39807556
Ole Maaløes Vej 3, 2200
København N
Activities of head offices
·
NACE 7010
Est. 2018 · 7 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Activities of head offices
/
Ebumab Holding ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JH
Johan Henrik Faber
Management
Management
2023
HH
Hans Heugh Wandall
Management
Management
2023
Former (1)
KF
Kurt Flemming Holmsted
Management
Management
2018 – 2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
SE
Søren Erik Bjørn
Board of Directors
Board of Directors
2023
JH
Johan Henrik Faber
Board of Directors
Board of Directors
2023
TD
Thomas Dal Stenfeldt Batchelor
Board of Directors
Board of Directors
2023
HH
Hans Heugh Wandall
Chairman
Chairman
2023
MN
Mads Nikolaj Behrndt-Eriksen
Board of Directors
Board of Directors
2023
Former (2)
KF
Kurt Flemming Holmsted
Board of Directors
Board of Directors
2018 – 2019
KS
Kim Stengaard Holmsted
Chairman
Chairman
2018 – 2020
Shareholders
As of last annual report
Johan H. Faber ApS — 50–66.65%
Wandall Holding ApS — 15–19.99%
Batchelor Holding ApS — 10–14.99%
Mabe Invest ApS — 5–9.99%
GV1 Holding ApS — 5–9.99%
DANSK CENTRALKONTOR FOR SOMMERHUS-UDLEJNING ApS — 25–33.32%
100%
Shareholder
Type
Ownership
Votes
Since
Johan H. Faber ApS
Company
50–66.65%
50–66.65%
2020
Wandall Holding ApS
Company
15–19.99%
15–19.99%
2020
Batchelor Holding ApS
Company
10–14.99%
10–14.99%
2020
Mabe Invest ApS
Company
5–9.99%
5–9.99%
2020
GV1 Holding ApS
Company
5–9.99%
5–9.99%
2020
DANSK CENTRALKONTOR FOR SOMMERHUS-UDLEJNING ApS
Company
25–33.32%
25–33.32%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ebumab Holding ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network